HRA005219
Title:
scEpiChem-cell line
Release date:
2024-05-21
Description:
We developed scEpiChem, an ultra-high-throughput method enabling the simultaneous detection of drug-target engagement and chromatin accessibility in single cell.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Cell line related study
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Helab at Peking University
Contact person:
He Aibin
Email:
ahe@pku.edu.cn
Description:
Helab is a research team at the College of Future Technology, Peking University, supervised by Professor Aibin He. Our focus is on the development of single-cell epigenetic technologies to investigate developmental processes and disease progression.
Individuals & samples
Submitter:   He Aibin / ahe@pku.edu.cn
Organization:   Peking University
Submission date:   2023-08-01
Requests:   -